Senores Pharmaceuticals, Ventive Hospitality, Carraro India. Share Listing on BSE NSE | Senores Pharmaceuticals shares listed at ₹600, up 53.45%: Ventiv Hospitality also listed up 11.7%; Carraro India’s entry down 7.53%

Listing Ceremony of Ventiv Hospitality on National Stock Exchange.

Shares of Senores Pharmaceuticals Ltd were listed today at ₹600 on the National Stock Exchange (NSE), 53.45% above the issue price. The shares listed at ₹593.70 on the Bombay Stock Exchange (BSE), 52% above the issue price. The issue price of Senores Pharmaceuticals’ IPO was ₹391.

Whereas, shares of Ventiv Hospitality Limited were listed on BSE at ₹718.15, 11.7% above the issue price. With this, this share was listed on NSE at ₹ 716, 11.3% above the issue price. The issue price of Ventiv Hospitality’s IPO was ₹643.

Whereas, shares of Carraro India Limited were listed at ₹651, 7.53% below the upper issue price on NSE. With this, this share was listed on BSE at ₹ 660, 6.25% below the upper issue price. The issue price of Carraro India’s IPO was ₹704. Let us now know about the issue size, bidding dates and other things of these three companies.

1. Senores Pharmaceuticals’ issue was worth ₹582.11 crore.

This IPO total of Senores Pharmaceuticals was ₹ 582.11 crore. For this, the company issued 1,27,87,723 fresh shares worth ₹500 crore. Existing investors of the company sold 21,00,000 shares worth ₹82.11 crore through Offer for Sale i.e. OFS.

Retail investors could bid for maximum 494 shares

Senores Pharmaceuticals Limited had fixed the price band of this issue at ₹372-₹391. Retail investors could bid for a minimum of one lot i.e. 38 shares. If you had applied for 1 lot as per the upper price band of IPO of ₹ 391, you would have had to invest ₹ 14,858.

At the same time, retail investors could apply for a maximum of 13 lots i.e. 494 shares. For this, investors would have to invest ₹ 1,93,154 as per the upper price band.

Senores Pharmaceuticals Limited was established in December 2017.

Senores Pharmaceuticals Limited, established in December 2017, is a global research driven pharmaceutical company. The company manufactures pharmaceutical products primarily for the US, Canada and UK markets.

The company’s product portfolio includes Amphetamine Sulphate Tablets, Hydroxychloroquine Sulphate Tablets, Ketoconazole Tablets, Butalbital, Acetaminophen and Caffeine Capsules, Mexiletine Hydrochloride Capsules, Ketorolac Tromethamine Tablets, Diclofenac Potassium Tablets, Diclofenac Potassium Tablets, Nicardipine Hydrochloride Capsules, Escitalopram Tablets, Prochlorperazine Maleate Tablets USP. , Terazosin Other medicines include Capsules USP, Morphine Sulfate Tablets, Methadone Hydrochloride Tablets, Cyclobenzaprine Hydrochloride Tablets and Irbesartan Tablets.

2. Ventiv Hospitality’s issue was worth ₹1,600 crore.

This IPO total of Ventiv Hospitality was ₹ 1,600 crore. For this, the company issued 2,48,83,358 fresh shares worth ₹ 1,600 crore. The company’s investors or promoters did not sell a single share.

Retail investors could bid for maximum 299 shares

Ventiv Hospitality Limited had fixed the price band of this issue at ₹610-₹643. Retail investors could bid for a minimum of one lot i.e. 23 shares. If you had applied for 1 lot as per the upper price band of IPO of ₹ 643, you would have had to invest ₹ 14,789.

At the same time, retail investors could apply for a maximum of 13 lots i.e. 299 shares. For this, investors would have to invest ₹ 1,92,257 as per the upper price band.

Ventiv Hospitality Limited was established in February 2002.

Established in February 2002, Ventiv Hospitality Limited is in the hospitality business. The company mainly deals with developing and managing luxury hotels and resorts. As of September 30, 2024, the company had 11 hospitality assets under management in India and Maldives.

Hospitality assets managed by Vantive Hospitality include hotels and resorts such as Marriott, Hilton, Miner and Atmosphere. As of September 30, 2024, there were 2,791 permanent employees in the company.

3. Carraro India’s issue was worth ₹1,250 crore

This IPO of Carraro India Limited was worth ₹ 1,250 crore. For this, the investors of the company sold 1,77,55,680 shares worth ₹ 1,250 crore through Offer for Sale i.e. OFS. The company did not issue even a single fresh share for the IPO.

Retail investors could bid for maximum 273 shares

Carraro India Limited had fixed the price band of this issue at ₹668-₹704. Retail investors could bid for a minimum of one lot i.e. 21 shares. If you had applied for 1 lot as per the upper price band of IPO of ₹ 704, you would have had to invest ₹ 14,784.

At the same time, retail investors could apply for a maximum of 13 lots i.e. 273 shares. For this, investors would have to invest ₹ 1,92,192 as per the upper price band.

What is IPO? When a company issues its shares to the general public for the first time, it is called Initial Public Offering i.e. IPO. The company needs money to expand its business. In such a situation, instead of taking loan from the market, the company raises money by selling some shares to the public or issuing new shares. For this the company brings IPO.